## Background: The prevalence and clinical characteristics of dystonia in huntington's disease (hd) have not been formally assessed. ## Objectives: To study (1) the prevalence of dystonia in hd in a clinic population, (2) the clinical features of dystonia, and (3) clinical correlates of dystonia
Clinical and genetic characteristics of Mexican Huntington's disease patients
✍ Scribed by María Elisa Alonso; Adriana Ochoa; Marie-Catherine Boll; Ana Luisa Sosa; Petra Yescas; Marisol López; Rosario Macias; Itziar Familiar; Astrid Rasmussen
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 348 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We report the characteristics of 691 Mexican patients with Huntington's disease (HD). These patients, representing 401 families, constitute the largest series of Mexican HD cases as yet described in the literature. We found the clinical characteristics of these patients to be similar to those of other populations, but we observed a higher frequency of infantile cases, a shorter disease duration and a lower suicide rate. In 626 cases, for which molecular analyses were available, CAG‐trinucleotide expansion size ranged from 37–106 repeats. The large number of CAG repeats (19.04 ± 3.02) in normal alleles and the presence of new mutations suggest that the overall prevalence of HD in the Mexican population could be expected to be within range of, or higher than, that reported for Europeans. © 2009 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract Huntington's disease (HD) classically presents with movement disorder, cognitive dysfunction and behavioral problems but is phenotypically variable. One percent of patients with HD‐like symptoms lack the causative mutation and are considered HD phenocopies. Genetic diseases known to cau
Assessment programs recently designed to follow-up patients with Huntington's disease (HD) in therapeutic trials have not included electrophysiological testing in the list of mandatory examinations. This omission is likely due to the current lack of data establishing a clear correlation between the
## Abstract Little is known about subjective perceptions of quality of life (QOL) in Huntington's disease (HD). The current study determined correlates of patient and caregiver QOL and assessed change over time. Participants were 22 patient‐caregiver dyads, who rated QOL at baseline and 6 months la